UBS Sticks to Its Buy Rating for UnitedHealth (UNH)
TD Cowen Sticks to Its Hold Rating for Humana (HUM)
Baird Adjusts Price Target on Humana to $205 From $264, Maintains Neutral Rating
Truist Financial Maintains Humana(HUM.US) With Hold Rating, Raises Target Price to $220
Truist Raises Price Target on Humana to $220 From $200, Keeps Hold Rating
Bernstein Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $211
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Humana (HUM) and Omnicell (OMCL)
Mizuho Securities Maintains Humana(HUM.US) With Buy Rating
Analysts Are Bullish on These Healthcare Stocks: Humana (HUM), Adagio Medical Holdings (ADGM)
Evercore ISI Adjusts Price Target on Humana to $195 From $180, Maintains In Line Rating
Wells Fargo & Co has raised its target price for Harmonia to $227.
Research Alert: Humana: 2027 Medicare Advantage Rate Supportive
Wells Fargo Maintains Equal-Weight on Humana, Raises Price Target to $227
BofA Securities Maintains Humana(HUM.US) With Hold Rating, Cuts Target Price to $210
Analysts Offer Insights on Healthcare Companies: Humana (HUM), Cigna (CI) and Intuitive Surgical (ISRG)
Wells Fargo Maintains Humana(HUM.US) With Hold Rating, Raises Target Price to $227
Bernstein Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $211
Wolfe Adjusts Price Target on Humana to $250 From $325, Maintains Outperform Rating
Bernstein Initiates Humana(HUM.US) With Buy Rating, Announces Target Price $211
Bernstein Sticks to Its Buy Rating for Humana (HUM)